Inmode Ltd
NASDAQ:INMD

Watchlist Manager
Inmode Ltd Logo
Inmode Ltd
NASDAQ:INMD
Watchlist
Price: 19.25 USD -1.38% Market Closed
Market Cap: 1.6B USD
Have any thoughts about
Inmode Ltd?
Write Note

Inmode Ltd
Cash from Operating Activities

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Inmode Ltd
Cash from Operating Activities Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Cash from Operating Activities CAGR 3Y CAGR 5Y CAGR 10Y
Inmode Ltd
NASDAQ:INMD
Cash from Operating Activities
$161.4m
CAGR 3-Years
0%
CAGR 5-Years
30%
CAGR 10-Years
N/A
Nano-X Imaging Ltd
NASDAQ:NNOX
Cash from Operating Activities
-$44.8m
CAGR 3-Years
-28%
CAGR 5-Years
-65%
CAGR 10-Years
N/A
B
Brainsway Ltd
TASE:BWAY
Cash from Operating Activities
$1.3m
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Sisram Medical Ltd
HKEX:1696
Cash from Operating Activities
$39.9m
CAGR 3-Years
-5%
CAGR 5-Years
13%
CAGR 10-Years
N/A
S
Sofwave Medical Ltd
TASE:SOFW
Cash from Operating Activities
-$6.3m
CAGR 3-Years
-10%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
E
Epitomee Medical Ltd
TASE:EPIT
Cash from Operating Activities
-$7.9m
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
No Stocks Found

Inmode Ltd
Glance View

Market Cap
1.6B USD
Industry
Health Care

InMode Ltd. designs, develops, manufactures and markets minimally-invasive aesthetic medical products. The company designs, develops, manufactures and commercializes energy-based, minimally-invasive surgical aesthetic and medical treatment solutions. The Company’s proprietary technologies are used by physicians to remodel subdermal adipose, or fatty, tissue in a variety of procedures including fat reduction with simultaneous skin tightening, face and body contouring and ablative skin rejuvenation treatments. Its products target a wide array of procedures including simultaneous fat killing and skin tightening, permanent hair reduction, skin appearance and texture, among others. The Company’s products may be used on a variety of body parts, including the face, neck, abdomen, upper arms, thighs and intimate feminine regions. The company owns six product platforms: BodyTite, Optimas, Votiva, Contoura, Triton and EmbraceRF. All are market and sell traditionally to plastic and facial surgeons, aesthetic surgeons and dermatologists, among others.

INMD Intrinsic Value
23.15 USD
Undervaluation 17%
Intrinsic Value
Price

See Also

What is Inmode Ltd's Cash from Operating Activities?
Cash from Operating Activities
161.4m USD

Based on the financial report for Sep 30, 2024, Inmode Ltd's Cash from Operating Activities amounts to 161.4m USD.

What is Inmode Ltd's Cash from Operating Activities growth rate?
Cash from Operating Activities CAGR 5Y
30%

Over the last year, the Cash from Operating Activities growth was -7%.

Back to Top